Rhode Island HB 7706: AN ACT RELATING TO BUSINESSES AND PROFESSIONS - PRESCRIPTION DRUG SALES - REPRESENTATIVE DISCLOSURE ACT (Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative and to pay an annual fee for each name listed with the department of business regulation.)

Status: 04/04/2018 Committee recommended measure be held for further study (as of 2018-04-04)

State: Rhode Island · Session: 2018 · Bill: HB 7706

Subjects: Business & Professions, Fees, Prescription drugs

Sponsors: Canario, Edwards, Kennedy, Newberry, Shekarchi

View Rhode Island HB 7706 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.